2016 Annual Report

ANNUAL REPORT

Message from the President

This year marks a turning point in the history of the Rheumatology Research Foundation as we expanded the breadth of our funding programs and successfully completed our largest fundraising initiative to date.  The momentum continues to accelerate the course of rheumatology research and training to improve the health of people with rheumatic disease.

 

In 2016, the Journey to Cure campaign to raise $60 million was successfully completed and went over goal by $1.4 million. This overwhelming success strengthened our awards program, which directly invests in rheumatology recruitment, education, and research. It would not have been possible without the support of the rheumatologists, health professionals, patients, families, and corporate institutions who donated to the Foundation this year and whose continued support is vital to our mission.

 

The Foundation is dedicated to fiscal responsibility and transparency, one of the many reasons that it continues to be ranked among the best charities in the nation year over year. The numbers reflected below are for Fiscal Year 2016 (July 1, 2015 – June 30, 2016). I invite you to learn more about the impact of our awards, the source of our funding, and the members of our community who make possible the journey to end rheumatic disease.

 

Eric L. Matteson, MD, MPH

President, Rheumatology Research Foundation

Chair, Mayo Clinic

Rochester, Minnesota

The Impact

The Rheumatology Research Foundation is a charitable organization dedicated to advancing research and training to improve the health of people with rheumatic disease.

 

Awardees are using their funding to investigate the following diseases:

 

• Inflammatory Arthritis

• Systemic Lupus Erythematosus

• Juvenile Idiopathic Arthritis

 

• Lupus

 

• Osteoarthritis

 

• Psoriatic Arthritis

 

• Rheumatoid Arthritis

 

• Scleroderma

 

With support from the Foundation, research may
also expand our knowledge of the origin and associated complications of rheumatic disease, including:

• Genetic and environmental causes

 

• Pain, fatigue, and cognitive issues

 

• Increased risk of cardiovascular disease

 

• Risk of biologic use before and after surgery

 

Awards granted

 

204

Research Awards

 

Fellowship Training Awards

 

Pediatric Visiting Professorships

 

Annual Meeting Awards

30

Annual Meeting Scholarships

 

Preceptorships

 

Health Professional Online Grants

 

 

 

 

 

39

23

17

19

59

17

$

Our progress in FY2016

Million Funded

13.2

101
38
11

Institutions

101 institutions in 38 states received funding from the Foundation.

 

Pediatric Visiting Professorships exposed students and residents to pediatric rheumatology.

States

49

Annual Meeting Awards and Scholarships exposed medical students and residents to rheumatology, encouraging them to choose rheumatology as their specialty.

Annual Meeting Scholarships provide funding to attend the ACR/ARHP Annual Meeting to students and residents in states underserved by rheumatology.

 

• Mississippi

 

• Nevada

 

• New Hampshire

 

• Arkansas

 

• Delaware

 

• Georgia

 

• Kentucky

 

• Louisiana

 

• Rhode Island

 

• South Carolina

• Iowa

 

• Kansas

 

• Hawaii

 

• Oklahoma

 

• Oregon

 

• Pennsylvania

 

• Maine

 

 

 Supporters

The generosity of our supporters is integral to our mission. Without the invaluable contributions of the rheumatology community, family members and friends, and the Corporate Roundtable, we could not spearhead the effort to end rheumatic disease.

 

Thank you to the members of the Corporate Roundtable

 

Leadership

 

 

 

 

Pinnacle

 

 

 

 

Principal

 

 

 

 

Partner

 

 

 



Executive

 

GlaxoSmithKline

 

999

Thank you to the donors whose support was vital to Foundation programming

 

Organizations

Patients, family members and friends

Rheumatologists and rheumatology

health professionals

26
206

Leadership

Board of Directors

 Financials

Rheumatology research and training is at the forefront of everything we do. Our high level of fiscal responsibility ranks us among the top 2% of charities in the nation and allows us to focus on what is the most important: the health of people living with rheumatic disease.

 

8 consecutive years

Click Here

For a closer look at our financials

Programs

 Administration

Fundraising

Staff

Mary Wheatley, IOM, CAE

Executive Director

Awards & Grants:

Eryn Marchiolo, MPH

Senior Director

 

Damian Smalls

Director

 

Sarah Barksdale

Senior Specialist

 

Kristen Gardner

Coordinator

 

Development:

Paula Reed

Vice President

 

[vacant]

Director

 

Cynthia Anderson

Regional Development Officer, South

 

Charlie Goldsmith

Regional Development Officer, West

 

Faith McGown

Regional Development Officer, Midwest

 

Jennifer Scanlon

Regional Development Officer, Northeast

 

Lauren Kenyon

Senior Specialist

 

Andrea Sharper

Coordinator

 

 

 

Marketing & COMMUNICATIONS:

Shelley Malcolm

Director

 

Kristin Andris

Specialist

 

[vacant]

Coordinator

 

Administration & Governance:

Heather Morgan

Coordinator

 

FINANCE:

Colleen Merkel, CPA

Vice President

 

Amber Burton, CPA

Senior Director

 

Grace Castillo

Senior Specialist

 

Corporate Relations:

Amy Miller

Director

 

86.2%

3.3%

10.5%

 

 

 

 

Back To Top             The Impact            Supporters             Financials             Leadership